What is the effect of nicardipine on the pregnant woman with severe hypertension and how is nicardipine excreted?
- Conditions
- Pregnant patients with preeclampsia (hypertension and protein/creatinine ratio = 30mg/mmol or = 300mg protein/24hours) complicated with severe hypertension (systolic bloodpressure = 160mmHg and/or diastolic blood pressure = 110mmHg). Gestational age = 20 weeksTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
- Registration Number
- EUCTR2012-005330-10-NL
- Lead Sponsor
- Erasmus University Medical Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Female
- Target Recruitment
- Not specified
Pregnant patients with preeclampsia (hypertension and protein/creatinine ratio = 30mg/mmol or = 300mg protein/24hours) complicated with severe hypertension (systolic bloodpressure = 160mmHg and/or diastolic blood pressure = 110mmHg)
gestational age = 20 weeks
working knowledge of Dutch language
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Fetal indication for immediate delivery, ie. signs of fetal distress: spontaneous repeated persistent unprovoked decelerations on CTG
Fetal death or major fetal congenital anomalies or estimated fetal weight below 500 grams
Placental abruption
Concomitant medication: nifedipine, cimetidine, labetalol
Clinically relevant pulmonary edema, defined as clinically relevant respiratory failure or severe respiratory distress requiring oxygen supplementation (more than 10 litres), with rales and/or pulse oximetry of <94% on room air
Eclampsia
Suspicion of (sub)capsular liverhematoma on physical examination
Renal failure (creatinine clearance < 40 mL/min)
• Suspicion of cerebro-vascular incident on physical examination
• Suspicion of trombo-embolism on physical examination
• Other severe maternal complications
• Maternal age <16 years
• Mentally incapacitated patient
• Impossible to place an intra-arterial catheter.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method